» Articles » PMID: 33141158

Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China

Overview
Journal JAMA Netw Open
Specialty General Medicine
Date 2020 Nov 3
PMID 33141158
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: Lung cancer screening has been widely implemented in Europe and the US. However, there is little evidence on participation and diagnostic yields in population-based lung cancer screening in China.

Objective: To assess the participation rate and detection rate of lung cancer in a population-based screening program and the factors associated with participation.

Design, Setting, And Participants: This cross-sectional study used data from the Cancer Screening Program in Urban China from October 2013 to October 2019, with follow-up until March 10, 2020. The program is conducted at centers in 8 cities in Henan Province, China. Eligible participants were aged 40 to 74 and were evaluated for a high risk for lung cancer using an established risk score system.

Main Outcomes And Measures: Overall and group-specific participation rates by common factors, such as age, sex, and educational level, were calculated. Differences in participation rates between those groups were compared. The diagnostic yield of both screening and nonscreening groups was calculated.

Results: The study recruited 282 377 eligible participants and included 55 428 with high risk for lung cancer; the mean (SD) age was 55.3 (8.1) years, and 34 966 participants (63.1%) were men. A total of 22 260 participants underwent LDCT (participation rate, 40.16%; 95% CI, 39.82%-40.50%). The multivariable logistic regression model showed that female sex (odds ratio [OR], 1.64; 95% CI, 1.52-1.78), former smoking (OR, 1.26; 95% CI, 1.13-1.41), lack of physical activity (OR, 1.19; 95% CI, 1.14-1.24), family history of lung cancer (OR, 1.73; 95% CI, 1.66-1.79), and 7 other factors were associated with increased participation of LDCT screening. Overall, at 6-year follow-up, 78 participants in the screening group (0.35%; 95% CI, 0.29%-0.42%) and 125 in the nonscreening group (0.38%; 95% CI, 0.33%-0.44%) had lung cancer detected, which resulted in an odds ratio of 0.93 (95% CI, 0.70-1.23; P = .61).

Conclusions And Relevance: The low participations rate in the program studied suggests that an improved strategy is needed. These findings may provide useful information for designing effective population-based lung cancer screening strategies in the future.

Citing Articles

The relationship between depression and cardiovascular disease in older people: results from a large-scale epidemiological cohort study in Japan.

Komuro K, Komuro J, Kaneko H, Suzuki Y, Okada A, Fujiu K Eur Geriatr Med. 2025; .

PMID: 39891821 DOI: 10.1007/s41999-024-01128-1.


Development of a Prediction Model and Risk Score for Self-Assessment and High-Risk Population Identification in Liver Cancer Screening: Prospective Cohort Study.

Li X, Wang Y, Li H, Wang L, Zhu J, Yang C JMIR Public Health Surveill. 2025; 10:e65286.

PMID: 39761122 PMC: 11702484. DOI: 10.2196/65286.


Interpretable machine learning model for digital lung cancer prescreening in Chinese populations with missing data.

Zhang S, Wang Q, Hu X, Zhang B, Sun S, Yuan Y NPJ Digit Med. 2024; 7(1):327.

PMID: 39562681 PMC: 11576743. DOI: 10.1038/s41746-024-01309-z.


Cost-effectiveness of lung cancer screening by low-dose CT in China: a micro-simulation study.

Du Y, Li Y, Sidorenkov G, Vliegenthart R, Heuvelmans M, Dorrius M J Natl Cancer Cent. 2024; 2(1):18-24.

PMID: 39035210 PMC: 11256619. DOI: 10.1016/j.jncc.2021.11.002.


Knowledge, attitude, and practice of lung cancer screening and associated factors among high-risk population in Lanzhou, China: A cross-sectional study.

Zhang T, Mao Z, Li W, Ma M, Li G, Qiao X Medicine (Baltimore). 2024; 103(9):e37431.

PMID: 38428855 PMC: 10906634. DOI: 10.1097/MD.0000000000037431.


References
1.
Aberle D, Adams A, Berg C, Black W, Clapp J, Fagerstrom R . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5):395-409. PMC: 4356534. DOI: 10.1056/NEJMoa1102873. View

2.
Chang J, Huang Y, Wei L, Ma B, Miao X, Li Y . Risk prediction of esophageal squamous-cell carcinoma with common genetic variants and lifestyle factors in Chinese population. Carcinogenesis. 2013; 34(8):1782-6. DOI: 10.1093/carcin/bgt106. View

3.
Guo L, Zhang S, Liu S, Zheng L, Chen Q, Cao X . Determinants of participation and detection rate of upper gastrointestinal cancer from population-based screening program in China. Cancer Med. 2019; 8(16):7098-7107. PMC: 6853828. DOI: 10.1002/cam4.2578. View

4.
Neal R, Sun F, Emery J, Callister M . Lung cancer. BMJ. 2019; 365:l1725. DOI: 10.1136/bmj.l1725. View

5.
Etemadi A, Abnet C, Golozar A, Malekzadeh R, Dawsey S . Modeling the risk of esophageal squamous cell carcinoma and squamous dysplasia in a high risk area in Iran. Arch Iran Med. 2012; 15(1):18-21. PMC: 3294378. DOI: 012151/AIM.007. View